| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | Anthem, Inc. | 60,000 | 6,457,000 | 0.08% | ||
| 102 | CARDIOVASCULAR SYS INC DEL COM | 206,000 | 6,419,000 | 0.08% | ||
| 103 | SUPERNUS PHARMACEUTICALS INC | 580,000 | 6,351,000 | 0.07% | ||
| 104 | CUBIST PHARMACEUTI | 90,000 | 6,284,000 | 0.07% | ||
| 105 | Vocera Communications Inc | 447,500 | 5,907,000 | 0.07% | ||
| 106 | ACCELERON PHARMA INC | 171,800 | 5,836,000 | 0.07% | ||
| 107 | MIMEDX GROUP INC COM | 795,400 | 5,639,000 | 0.07% | ||
| 108 | PUMA BIOTECHNOLOGY | 85,000 | 5,610,000 | 0.07% | Call | |
| 109 | TEVA PHARMACEUTICAL INDS LTD | 100,000 | 5,242,000 | 0.06% | Call | |
| 110 | National Australia Bank ADR | 100,000 | 5,156,000 | 0.06% | Call | |
| 111 | CATALYST PHARMACEUTICALS INC | 1,895,000 | 4,794,000 | 0.06% | ||
| 112 | DAVITA INC | 65,000 | 4,701,000 | 0.06% | ||
| 113 | PTC THERAPEUTICS INC | 178,100 | 4,656,000 | 0.05% | ||
| 114 | IRONWOOD PHARMACEUTICALS INC | 300,000 | 4,599,000 | 0.05% | Call | |
| 115 | FATE THERAPEUTICS INC | 692,900 | 4,372,000 | 0.05% | ||
| 116 | UROPLASTY INC | 1,363,500 | 3,654,000 | 0.04% | ||
| 117 | Curis, Inc | 1,950,100 | 3,627,000 | 0.04% | ||
| 118 | BOSTON SCIENTIFIC CORP | 271,700 | 3,470,000 | 0.04% | ||
| 119 | DERMA SCIENCES ORD | 300,000 | 3,468,000 | 0.04% | ||
| 120 | PROSENSA HLDG N V SHS USD | 264,000 | 3,332,000 | 0.04% | ||
| 121 | ANGIODYNAMICS INC | 200,000 | 3,266,000 | 0.04% | Call | |
| 122 | ANTHERA PHARMACEUTICALS I | 932,750 | 3,162,000 | 0.04% | ||
| 123 | NEWLINK GENETICS CORP COM | 100,000 | 2,655,000 | 0.03% | Call | |
| 124 | VOLCANO CORPORATION | 15,000,000 | 2,642,000 | 0.03% | PRN | |
| 125 | BIOLINERX LTD | 1,135,000 | 2,361,000 | 0.03% | ||
| 126 | CERUS CORP | 500,000 | 2,075,000 | 0.02% | Call | |
| 127 | ENDOLOGIX INC | 1,000,000 | 1,003,000 | 0.01% | PRN | |
| 128 | AMARIN CORP PLC | 400,000 | 704,000 | 0.01% | ||
| 129 | BIOMARIN PHARMACEUTICAL INC SR SB CONV NT 20 | 500,000 | 540,000 | 0.01% | ||
| 130 | BIOMARIN PHARMACEUTICAL INC 0.75 10/15/2018 | 500,000 | 515,000 | 0.01% | ||
| 131 | BIODEL INC | 209,700 | 453,000 | 0.01% | ||
| 132 | ZOGENIX INC | 207,600 | 417,000 | 0.00% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-14-001491, filed 2014.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
